Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Chemical Biology|March 11, 2014
Metal-based anticancer chemotherapeutic agentsNafees Muhammad, Zijian Guo
Chemistry, an Asian Journal|July 7, 2021
Redirecting Cisplatin and Doxorubicin to Mitochondria Affords Highly Effective PlatinumIV Prodrug Against Triple Negative Breast CancerNafees Muhammad, Tan Cai-Ping, Sadia Nasreen, et al.
Chemical Reviews|October 10, 2018
Stimuli-Responsive Therapeutic MetallodrugsXiaohui Wang, Xiaoyong Wang, Suxing Jin, et al.
Chemical Communications (Cambridge, England)|August 24, 2017
Biotin-tagged platinum(iv) complexes as targeted cytostatic agents against breast cancer cellsNafees Muhammad, Nasreen Sadia, Chengcheng Zhu, et al.
Dalton Transactions (Cambridge, England : 2003)|June 24, 2016
Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapyNafees Muhammad, Xiaoyong Wang, Kun Wang, et al.
Angewandte Chemie (International Ed. in English)|September 8, 2020
Multispecific Platinum(IV) Complex Deters Breast Cancer via Interposing Inflammation and Immunosuppression as an Inhibitor of COX-2 and PD-L1Suxing Jin, Nafees Muhammad, Yuewen Sun, et al.
Angewandte Chemie (International Ed. in English)|January 30, 2019
Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion-Targeted Platinum(II) ComplexKun Wang, Chengcheng Zhu, Yafeng He, et al.
Inorganic Chemistry|August 18, 2018
Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) ComplexesSuxing Jin, Yigang Hao, Zhenzhu Zhu, et al.
Inorganic Chemistry|August 26, 2020
Multiaction Platinum(IV) Prodrug Containing Thymidylate Synthase Inhibitor and Metabolic Modifier against Triple-Negative Breast CancerNafees Muhammad, Cai-Ping Tan, Uroosa Nawaz, et al.
Pageof 1